FI106962B - Menetelmä (1R, 5S, 6S)-2-[1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli]-tio-6-[(R)-1-hydroksietyyli]-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi - Google Patents

Menetelmä (1R, 5S, 6S)-2-[1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli]-tio-6-[(R)-1-hydroksietyyli]-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI106962B
FI106962B FI943164A FI943164A FI106962B FI 106962 B FI106962 B FI 106962B FI 943164 A FI943164 A FI 943164A FI 943164 A FI943164 A FI 943164A FI 106962 B FI106962 B FI 106962B
Authority
FI
Finland
Prior art keywords
compound
formula
group
compounds
thio
Prior art date
Application number
FI943164A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943164A0 (fi
FI943164A (fi
Inventor
Takao Abe
Satoshi Tamai
Chisato Sato
Ado Mihira
Takeshi Isoda
Toshio Kumagai
Original Assignee
Wyeth Lederle Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Lederle Japan Ltd filed Critical Wyeth Lederle Japan Ltd
Publication of FI943164A0 publication Critical patent/FI943164A0/fi
Publication of FI943164A publication Critical patent/FI943164A/fi
Application granted granted Critical
Publication of FI106962B publication Critical patent/FI106962B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI943164A 1993-07-01 1994-07-01 Menetelmä (1R, 5S, 6S)-2-[1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli]-tio-6-[(R)-1-hydroksietyyli]-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi FI106962B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP21330693 1993-07-01
JP21330693 1993-07-01
JP7932094 1994-03-28
JP7932094 1994-03-28
JP12204694 1994-05-12
JP12204694 1994-05-12

Publications (3)

Publication Number Publication Date
FI943164A0 FI943164A0 (fi) 1994-07-01
FI943164A FI943164A (fi) 1995-01-02
FI106962B true FI106962B (fi) 2001-05-15

Family

ID=27302982

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943164A FI106962B (fi) 1993-07-01 1994-07-01 Menetelmä (1R, 5S, 6S)-2-[1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli]-tio-6-[(R)-1-hydroksietyyli]-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi

Country Status (16)

Country Link
US (2) US5534510A (pt)
EP (2) EP0924210B1 (pt)
JP (1) JP2666118B2 (pt)
KR (1) KR100331293B1 (pt)
AT (2) ATE212636T1 (pt)
AU (1) AU682510B2 (pt)
CA (1) CA2127193C (pt)
DE (2) DE69433955T2 (pt)
DK (2) DK0924210T3 (pt)
ES (2) ES2170080T3 (pt)
FI (1) FI106962B (pt)
HU (1) HU220609B1 (pt)
IL (1) IL110161A (pt)
NO (2) NO306780B1 (pt)
PT (2) PT924210E (pt)
TW (1) TW254943B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783703A (en) * 1993-07-01 1998-07-21 Lederle (Japan), Ltd. Sulfur-containing compounds method for their use and prodction
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
ATE201410T1 (de) * 1994-12-12 2001-06-15 Wyeth Lederle Japan Ltd Verfahren zur herstellung von 1-(4,5-dihydro)2- thiazolyl-3-azetidinthiolderivaten
TW420681B (en) * 1995-12-08 2001-02-01 Lederle Japan Ltd Carbapenem-3-carboxylic acid ester derivatives
ATE223216T1 (de) 1996-05-09 2002-09-15 Sankyo Co Anti-helicobacter pylori zusammensetzungen die 1- methylcarbapenem-derivate als wirkstoffe enthalten
KR20010079713A (ko) * 1998-09-10 2001-08-22 마쓰자와 도로, 하야시 지로 카르바페넴 화합물
KR100325375B1 (ko) * 2000-01-31 2002-03-06 박호군 이미다졸린 고리가 치환된 카바페넴 유도체
BR0115454A (pt) * 2000-11-16 2003-09-23 Sankyo Co Composto de 1-metilcarbapenem ou um sal ou derivado de éster deste farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto ou de um sal ou derivado de éster deste farmaceuticamente aceitável
KR100441406B1 (ko) * 2001-09-05 2004-07-23 한국과학기술연구원 티아졸리딘 고리 치환체를 갖는 1-β-메틸 카바페넴유도체 및 그 제조 방법
KR100451670B1 (ko) * 2001-09-14 2004-10-08 한국화학연구원 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
JP4377231B2 (ja) 2001-11-05 2009-12-02 大日本住友製薬株式会社 新規なカルバペネム化合物
TW200403244A (en) * 2002-05-14 2004-03-01 Sankyo Co 1β-Methylcarbapenem derivatives for oral use
JP4694370B2 (ja) 2002-10-18 2011-06-08 明治製菓株式会社 マロン酸モノエステルおよびその製造方法
JPWO2004035539A1 (ja) * 2002-10-18 2006-02-16 明治製菓株式会社 カルバペネム類の製造方法およびその製造に用いられる中間体
EP1580191A4 (en) * 2002-11-13 2011-03-02 Kaneka Corp PROCESS FOR PRODUCING CARBAPENEM COMPOUND FOR ORAL ADMINISTRATION
EP1612211A4 (en) * 2003-04-08 2008-07-02 Dainippon Sumitomo Pharma Co NEW CARBAPENEM COMPOUNDS
CN1897907B (zh) * 2003-12-30 2012-06-20 麦迪斯技术公司 带有移动控制的超声治疗头
EP1627891A1 (en) * 2004-08-11 2006-02-22 Covion Organic Semiconductors GmbH Polymers for use in organic electroluminescent devices
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
EP1785426A4 (en) * 2004-09-03 2008-02-20 Dainippon Sumitomo Pharma Co NEW CARBAPENEM DERIVATIVE
JP2006176418A (ja) * 2004-12-21 2006-07-06 Kaneka Corp 経口投与用カルバペネム化合物の製造方法と新規β−ラクタム化合物
EP1864985A4 (en) * 2005-03-25 2010-01-06 Dainippon Sumitomo Pharma Co NEW CARBAPENEM COMPOUND
KR100723889B1 (ko) 2006-06-30 2007-05-31 주식회사 하이닉스반도체 직렬 입/출력 인터페이스를 가진 멀티 포트 메모리 소자
JP5013795B2 (ja) * 2006-09-25 2012-08-29 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 経口投与用カルバペネム
JP2010540433A (ja) * 2007-09-20 2010-12-24 クジェ ファーマシューティカル インダストリアル カンパニー リミテッド カルバペネム系抗生物質の合成中間体の酸付加塩及びその製造方法
JP2011504495A (ja) * 2007-11-23 2011-02-10 クジェ ファーマシューティカル インダストリアル カンパニー リミテッド ２−アリールメチルアゼチジン−カルバペネム−３−カルボン酸エステル誘導体またはその塩、その製造方法及びそれを含む医薬組成物
CN102558181B (zh) * 2010-12-15 2015-04-22 石药集团中奇制药技术（石家庄）有限公司 一种碳青霉烯抗生素的制备方法
CN102731507B (zh) * 2011-04-13 2015-04-01 石药集团中奇制药技术（石家庄）有限公司 泰比培南晶型、其制备方法及其在制备药物中的应用
CN103059026A (zh) * 2011-10-20 2013-04-24 北京康健源科技有限公司 一种替比培南匹夫酯的制备方法
CN102584812B (zh) * 2011-11-18 2014-03-12 深圳万乐药业有限公司 一种泰比培南酯杂质的制备方法
CN102503940B (zh) * 2011-11-22 2013-12-25 深圳万乐药业有限公司 制备泰比培南酯开环杂质的方法
CN103059027A (zh) * 2012-12-20 2013-04-24 安徽悦康凯悦制药有限公司 替比培南匹伏酯的制备方法
KR102640532B1 (ko) * 2016-12-15 2024-02-26 스페로 테라퓨틱스, 인코퍼레이티드 신규한 테비페넴 피복실 속방형 및 변형 방출형 경구 투여형
EA201991618A1 (ru) 2017-02-06 2020-01-30 Сперо Терапьютикс, Инк. Кристаллические формы тебипенема пивоксила, композиции, содержащие их, способы изготовления и способы применения
CN110698469A (zh) * 2019-10-28 2020-01-17 南京红杉生物科技有限公司 泰比培南酯中间体及其合成方法、应用
AU2021378320A1 (en) 2020-11-11 2023-06-22 Spero Therapeutics, Inc. High dosage tebipenem pivoxil tablet formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3665001A (en) * 1970-06-11 1972-05-23 Exxon Research Engineering Co Azinyl organophosphorus compounds
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
US4696923A (en) * 1984-04-23 1987-09-29 Merck & Co., Inc. 6-[1-hydroxyethyl]-2-SR8 -1-methyl-1-carbadethiapen-2-em-3-carboxylic acids
JPS63255280A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk （１ｒ，５ｓ，６ｓ）−２−置換−６−〔（ｒ）−１−ヒドロキシエチル〕−１−メチル−カルバペネム−３−カルボン酸誘導体
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation

Also Published As

Publication number Publication date
EP0924210A1 (en) 1999-06-23
NO991019L (no) 1995-01-02
ATE273975T1 (de) 2004-09-15
IL110161A (en) 1998-09-24
FI943164A0 (fi) 1994-07-01
IL110161A0 (en) 1994-10-07
CA2127193C (en) 2005-04-12
EP0632039B1 (en) 2002-01-30
EP0924210B1 (en) 2004-08-18
DK0632039T3 (da) 2002-05-13
NO991019D0 (no) 1999-03-02
ES2170080T3 (es) 2002-08-01
AU6598794A (en) 1995-01-12
ATE212636T1 (de) 2002-02-15
DE69433955T2 (de) 2005-09-08
EP0632039A1 (en) 1995-01-04
CA2127193A1 (en) 1995-01-02
US5679790A (en) 1997-10-21
NO306780B1 (no) 1999-12-20
HU220609B1 (hu) 2002-03-28
JPH0853453A (ja) 1996-02-27
JP2666118B2 (ja) 1997-10-22
DE69429742D1 (de) 2002-03-14
PT924210E (pt) 2004-12-31
NO942483D0 (no) 1994-06-30
NO942483L (no) 1995-01-02
KR100331293B1 (ko) 2002-10-25
DK0924210T3 (da) 2004-12-13
FI943164A (fi) 1995-01-02
TW254943B (pt) 1995-08-21
DE69429742T2 (de) 2002-06-06
US5534510A (en) 1996-07-09
KR950003292A (ko) 1995-02-16
AU682510B2 (en) 1997-10-09
HUT68057A (en) 1995-05-29
ES2222630T3 (es) 2005-02-01
HU9401957D0 (en) 1994-09-28
NO307379B1 (no) 2000-03-27
PT632039E (pt) 2002-06-28
DE69433955D1 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
FI106962B (fi) Menetelmä (1R, 5S, 6S)-2-[1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli]-tio-6-[(R)-1-hydroksietyyli]-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI84826C (fi) Foerfarande foer framstaellning av 6 -(1-hydroxietyl-2-substituerad-2-karbapenem-3-karboxylsyror anvaendbara som laekemedel.
FI83419B (fi) Foerfarande foer framstaellning av som laekemedel anvaendbara 1,2,6-substituerad karbapen-2-em-3-karboxylsyra.
FI96863C (fi) Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi
CZ286878B6 (en) Carbapenems, process of their preparation, intermediates for their preparation, those carbapenems used for treating infections and pharmaceutical preparations
US5153187A (en) 1-methylcarbapenem derivatives and process for preparation thereof
AU705408B2 (en) Carbapenem-3-carboxylic acid ester derivatives
US5783703A (en) Sulfur-containing compounds method for their use and prodction
NZ249947A (en) Carbapenem derivatives, medicaments, and precursors
EP0368259B1 (en) Carbapenem derivatives
AU710881B2 (en) 1-methylcarbapenem derivatives
US5208348A (en) Mercaptan compound
US6479478B1 (en) Carbapenem compounds
US5527793A (en) Antibiotic carbapenem compounds
JP2003183282A (ja) カルバペネム化合物
JP2003183281A (ja) カルバペネム化合物
JP2003183280A (ja) カルバペネム化合物
JPH07196660A (ja) ２−（ヘテロシクロアルケニルアルキル）チオカルバペネム誘導体
JP2003104893A (ja) １−メチルカルバペネム化合物を含有する抗菌剤
WO2001057041A1 (fr) Composes 1-methylcarbapedem
JP2000086667A (ja) カルバペネム化合物
JP2001288186A (ja) １−メチルカルバペネム化合物
JPH0717977A (ja) （１ｒ，５ｓ，６ｓ）−２−［（４−置換−１，３−チアゾール−２−イル）アミノカルボニルメチルチオ］−６−［（ｒ）−１−ヒドロキシエチル］−１−メチル−カルバペン−２−エム−３−カルボキシレート

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: PFIZER JAPAN INC.

Free format text: PFIZER JAPAN INC.

MA Patent expired